Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE: ABT). A ...

Lastly, medical devices represent more than ... a strong leading position in their continuous glucose monitoring system with their Freestyle Libre brand. GLP-1 drugs have been rapidly adopted ...

Apple might disrupt the world of consumer tech once again. The US-based tech giant has reportedly developed a secret app that monitors blood sugar. The company is testing two tools to try and ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the ... new data integration with continuous glucose monitoring (CGM) manufacturer Abbott ...

We are excited to partner with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre devices on Tidepool and Tidepool+,” said Brandon ...